Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 11, 2010

Roche Diagnostics Purchases Microarray Instrument and Accessory Assets from BioMicro Systems

  • Roche Diagnostics purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow. These assets include the NimbleGen Hybridization Systems (both 4- and 12-bay models) and array accessories covering all mixers designed for the Roche NimbleGen high-density microarray portfolio.

    With the purchase of these assets, Roche Diagnostics will transfer the manufacturing capabilities for the above products to an in-house manufacturing facility. “The acquired products are integral to the high-quality data the NimbleGen array workflow provides researchers worldwide,” points out Andreas Görtz, vp of marketing at Roche NimbleGen.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »